Alcoholism worsens the survival of patients with hepatitis B virus and C virus-related hepatocellular carcinoma
- PMID: 26201797
- DOI: 10.1007/s12072-012-9375-2
Alcoholism worsens the survival of patients with hepatitis B virus and C virus-related hepatocellular carcinoma
Abstract
Background/aims: Chronic hepatitis B and hepatitis C virus (HBV, HCV) infection and alcoholism are common etiologies for hepatocellular carcinoma (HCC). The characteristics and impact of alcoholism and/or HCV/HBV infection on HBV- and HCV-related HCC, respectively, are investigated in this study.
Methods: A total of 1,888 patients were retrospectively investigated and categorized into six groups, HBV only (n = 977), HBV with alcoholism (n = 197), HCV only (n = 544), HCV with alcoholism (n = 67), dual HBV and HCV (n = 82), and dual virus with alcoholism (n = 21), to examine their interactions on the outcome.
Results: Compared to their counterparts, alcoholic patients coinfected with HBV and/or HCV tended to be younger, had higher male-to-female ratios, worse performance status, more severe liver cirrhosis, advanced cancer staging, and tumor burden than patients without alcoholism. In survival analysis, patients with HBV with alcoholism had a significantly decreased survival than the HBV-only group (p = 0.001). A shortened survival was also observed in HCV with alcoholism group compared to the HCV-only group (p = 0.011). Dual virus infection with alcoholism did not significantly worsen the survival compared to the dual virus infection group. In the Cox proportional hazards model, HBV with alcoholism group [risk ratio (RR) 1.299, p = 0.032] and HCV with alcoholism (RR 1.523, p = 0.025) group were independent predictors associated with decreased survival compared to their counterpart of HBV- and HCV-only groups.
Conclusions: Alcoholism in patients with HBV or HCV infection is characterized by early development of HCC with advanced cirrhosis and cancer staging at diagnosis. Alcoholism independently predicts an increased risk of mortality in patients with HBV- and HCV-related HCC.
Keywords: Alcoholism; Dual virus infection; HBV; HCV; Hepatocellular carcinoma.
Similar articles
-
Characteristics and outcome of patients with dual hepatitis B and C-associated hepatocellular carcinoma: are they different from patients with single virus infection?Liver Int. 2009 May;29(5):767-73. doi: 10.1111/j.1478-3231.2008.01908.x. Epub 2008 Nov 3. Liver Int. 2009. PMID: 19018974
-
Differences in surgical outcomes between hepatitis B- and hepatitis C-related hepatocellular carcinoma: a retrospective analysis of a single North American center.Ann Surg. 2014 Oct;260(4):650-6; discussion 656-8. doi: 10.1097/SLA.0000000000000917. Ann Surg. 2014. PMID: 25203882
-
A comparison of the surgical outcomes among patients with HBV-positive, HCV-positive, and non-B non-C hepatocellular carcinoma: a nationwide study of 11,950 patients.Ann Surg. 2015 Mar;261(3):513-20. doi: 10.1097/SLA.0000000000000821. Ann Surg. 2015. PMID: 25072437
-
Hepatitis C virus in chronic liver disease and hepatocellular carcinoma in Taiwan.Princess Takamatsu Symp. 1995;25:27-32. Princess Takamatsu Symp. 1995. PMID: 8875606 Review.
-
Coinfection of Schistosoma Species with Hepatitis B or Hepatitis C Viruses.Adv Parasitol. 2016;91:111-231. doi: 10.1016/bs.apar.2015.12.003. Epub 2016 Feb 5. Adv Parasitol. 2016. PMID: 27015949 Review.
Cited by
-
α-fetoprotein-to-total tumor volume ratio predicts post-operative tumor recurrence in hepatocellular carcinoma.J Gastrointest Surg. 2013 Apr;17(4):730-8. doi: 10.1007/s11605-012-2081-5. Epub 2012 Nov 28. J Gastrointest Surg. 2013. PMID: 23188220
-
Decrypting cryptogenic hepatocellular carcinoma: clinical manifestations, prognostic factors and long-term survival by propensity score model.PLoS One. 2014 Feb 24;9(2):e89373. doi: 10.1371/journal.pone.0089373. eCollection 2014. PLoS One. 2014. PMID: 24586728 Free PMC article.
-
Impact of tumor burden on prognostic prediction for patients with terminal stage hepatocellular carcinoma: A nomogram study.PLoS One. 2017 Nov 10;12(11):e0188031. doi: 10.1371/journal.pone.0188031. eCollection 2017. PLoS One. 2017. PMID: 29125877 Free PMC article.
-
Using serum α-fetoprotein for prognostic prediction in patients with hepatocellular carcinoma: what is the most optimal cutoff?PLoS One. 2015 Mar 4;10(3):e0118825. doi: 10.1371/journal.pone.0118825. eCollection 2015. PLoS One. 2015. PMID: 25738614 Free PMC article.
-
A New Treatment-integrated Prognostic Nomogram of the Barcelona Clinic Liver Cancer System for Hepatocellular Carcinoma.Sci Rep. 2017 Aug 11;7(1):7914. doi: 10.1038/s41598-017-08382-3. Sci Rep. 2017. PMID: 28801646 Free PMC article.
References
LinkOut - more resources
Full Text Sources